about
AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 traffickingAcne and Telomere Length: A New Spectrum Between Senescence and Apoptosis PathwaysEndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factorGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanismsTmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjectsA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.Negligible impact of rare autoimmune-locus coding-region variants on missing heritabilityIdentification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques.Angiogenesis in psoriasis.Genetic association analysis using data from triads and unrelated subjectsInfliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.The European Genome-phenome Archive of human data consented for biomedical research.Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants.Searching for the major histocompatibility complex psoriasis susceptibility gene.Elevated expression and genetic association links the SOCS3 gene to atopic dermatitisDiagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci.Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures.An update on the genetics of psoriasis.Cutaneous lymphocyte trafficking in the inflammatory dermatoses.Psoriasis and other complex trait dermatoses: from Loci to functional pathways.Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6.Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum.Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis.Update on psoriasis immunopathogenesis and targeted immunotherapy.Keratinocytes as initiators of inflammation.Psoriasis in practice.Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.Polymorphisms in the PTPN22 region are associated with psoriasis of early onset.Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis.Psoriasis: consensus on topical therapies.Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patientsOutcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms.Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis surveyAP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 ProductionPsoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland.
P50
Q24296788-A5F04F08-B0F5-4643-9301-07A62A004F55Q28005562-71842732-473D-4A41-884C-39DE5A8D73BAQ28205813-0E5FDA5D-25B2-4EFA-9AF4-A0845D5013C0Q28385664-2F71BB94-636F-4B1D-86BD-09CCAF74F681Q28511427-63926357-9102-4294-9C58-20B70CF26B79Q29417009-FB6A697D-E73B-442A-85A6-13996C249457Q30415780-F18693E9-167E-464A-8605-F60DAC1C1784Q30419116-FEED39D6-42D6-4493-925F-E0667C9395AFQ30469652-258372AA-FA11-42A7-A333-C814D4424E4AQ30706232-25019FF1-7AF2-4780-B825-CCD796217B02Q33188061-3017994A-ADC1-45B0-ACB2-B443496EB80EQ33211937-205C0DD8-14C7-4371-9585-5F17A36859F2Q33371653-44E4D668-333E-4007-9C88-BACAFF8354C0Q33663109-0C5D9CD7-BBBA-4ED2-9F36-E9C35C2EAAF8Q33761227-96716897-411F-424F-AE78-618D9CB8B94BQ34619466-49CAAE85-9B5F-49AB-B69F-CF58E3212567Q34658329-385C71C0-6A3C-4591-8524-5280030E06C6Q35109287-2672CA80-68CA-49C4-8453-5586DB28839EQ35435900-30619EB0-EF6F-4908-8652-E420AC478FC2Q35470124-A09EF194-61A1-4783-BBE1-C1AE8A117B96Q35902652-CBEB3AE7-13F4-46A3-8D47-179641220526Q35951520-7037864A-B639-4620-9823-34F158A8F687Q36043340-FFEEACEB-C7C8-40D6-BA08-F133BC4CFC21Q36066801-4019BD04-1A6A-426C-8194-37759254BDD1Q36305883-8159A2F8-A60A-41D6-9B64-3E206B2CCEBDQ36375800-09ED789E-424B-41D2-988E-4B23E8DB697AQ36445919-8EA96E31-CBBD-4367-88AC-547A7D0B9A42Q36481727-1763ECE4-0D96-4982-996E-147D3C602748Q36503539-F7DFAE3C-3FFC-4D28-967C-611D51A8B695Q36572788-88DF95E6-99EE-4BBD-9954-51AB85884748Q36590346-214D0777-C6AB-4090-B2AC-A1BB62923421Q36751614-1EE1CF58-AB34-46B9-8A65-25856BBD811FQ37032806-A902E539-8E9E-4AD1-91F4-16C63AFDB168Q37114851-030F0FA7-7DD4-45DF-8F3C-BA0D3EDD6834Q37187173-3A20BA0D-1541-4DDB-9D5B-1C9F2CCB1D35Q37187337-9D14A377-FAAA-409D-BE81-704AE13AF509Q37268881-15B0D6B1-C221-48BC-BE8B-B07164F0B278Q37351626-83973F3C-C39F-4A0B-994B-0D408E537131Q37743164-78652981-D82D-4FFF-872A-02C94D4D0A82Q37935050-29D21DF7-C03D-46C3-9A95-1224D7AFCBDF
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan N Barker
@nl
Jonathan N Barker
@sl
Jonathan N. Barker
@en
Jonathan N. Barker
@es
type
label
Jonathan N Barker
@nl
Jonathan N Barker
@sl
Jonathan N. Barker
@en
Jonathan N. Barker
@es
altLabel
Barker J
@en
Barker JN
@en
Barker JNWN
@en
Jonathan Barker
@en
prefLabel
Jonathan N Barker
@nl
Jonathan N Barker
@sl
Jonathan N. Barker
@en
Jonathan N. Barker
@es
P214
P244
P106
P1153
7401680615
P21
P214
P244
n2015187367
P31
P496
0000-0002-9030-183X
P734
P735
P7859
lccn-n2015187367